Skip to main content
. 2021 Dec 18;61(13):1987–1993. doi: 10.2169/internalmedicine.8594-21

Table 4.

Baseline Characteristics.

Characteristic Pt.1 Pt.2 Pt.3 Pt.4 Pt.5
Age 56 29 44 57 35
Sex F F M F F
Disease onset HF HF HF HF VT
Family history
DCM + + + + -
SCD <45y - - + - -
Symptoms
Syncope - - - - +
NYHA II III III II I
ECG abnormalities
Low voltage - - - + +
Reduced R amplitude - + + + +
Repolarization abnormalities + - - - -
TTE
LVDd/LVDs (mm) 53/44 68/59 74/71 54/48 46/43
IVS/PW (mm) 9/6 9/7 10/10 8/8 8/6
LVEF (%) 35 35 9 24 30

‘Low voltage’ is defined as QRS peak-to-peak amplitude in leads I, II, and III <0.5 mV, the sum of the amplitudes <1.5 mV, and amplitude in all precordial leads <1.0 mV (3). ‘Reduced R amplitude’ is defined as R waves <3 mm for at least five of six limb leads or <5 mm for five of six precordial leads (8). ‘Repolarization abnormalities’ is defined as fulfilling the major or minor criteria as described in the modified ARVC/D task force criteria (18).

ARVC/D: arrhythmogenic right ventricular cardiomyopathy/dysplasia, DCM: dilated cardiomyopathy, ECG: electrocardiogram, IVS: interventricular septum, LVDd: left ventricular end-diastolic dimension, LVDs: end-systolic dimension, LVEF: left ventricular ejection fraction, PW: posterior wall, SCD: sudden cardiac death, TTE, transthoracic echocardiography